Acute Leukemias Flashcards

(108 cards)

1
Q

BM failure causes what 3 things in acute leukemia?

A
  • Anemia
  • Infection
  • Hemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute vs. chronic

- Organomegaly

A

Acute: mild
Chronic: prominent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the two types of APL has hypergranular promyelocytes and nuclei that are often bi-lobed or kidney shaped?

A

Typical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Treatment/Therapy: type of medication that blocks growth of cancer cells by interfering with specific target molecules. More effective and less harmful than traditional methods

A

Targeted treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

While oncogenes act in a dominant fashion, tumor suppressor genes transform cells into a malignant phenotype only after _______ _______ have been lost or inactivated. WHAT theory is this?

A

BOTH alleles (2 hit theory by Knudson)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute lymphoblastic leukemia (ALL)

- Immunophenotying for B cell leukemias and T cell leukemias

A

B: CD10+, CD19+, CD20+/-
T: CD2+, CD3+, CD4+, CD5+, CD7+; CD8+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute lymphoblastic leukemia (ALL)

- what percentags fall w/in different white cell ranges?

A
  • Normal WBC → 25%
  • 5-25 x 10^9/L → 50%
  • > 100 x 10^9/L → 10%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute vs. chronic

- Clinical onset

A

Acute: sudden
Chronic: slow/insidious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acute lymphoblstic leukemia (ALL) is most common in who?

A

Children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

FAB nomenclature for AML-NOS Acute monocytic leukemia

A

M5b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute leukemia BM production

A

Reduced BM production

  • Erythrocytes → anemia
  • Granulocytes → neutropenia
  • Platelets → thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute vs. chronic

- Anemia

A

Acute: mild to severe
Chronic: mild

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AML w/ abnormal marrow eosinophils in the peripheral blood

A
  • Myeloblasts (other immature myeloid cells)
  • Monocytoid cells
  • Thrombocytopenia
  • Normal eos
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AML w/ myelodysplasia-related changes

- Lab findings

A

Presents w/ severe pancytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(M1) AML-NOS Without Maturation

  • Blast percentage
  • MPO/SBB stain?
  • Auer rods?
A
  • > 90% of non-erythroid cells
  • MPO/SBB > 3% (positive)
  • Auer rods (+/-)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Genes that cause dominant-acting cancer mutations (one copy)

A

Oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment/Therapy: Replacement of the patient’s hematopoietic stem cells

A

Stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

AML w/ maturation in the bone marrow

A
  • Dysplasia in the neutrophil line (monos, eos, and erythroids, components not affected)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Malignancies of the hematopoietic system are usually ____

A

Acquired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What does it mean if you have > 20% blasts in the PB or BM?

A

That is the WHO classification for acute leukemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AML w/ maturation

- Cytogenetic abnormality

A

t(8;21)(q22;q22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Two types of stem cell transplants

A
  • Allogenic

- Autologous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

(M5a) AML-NOS-Acute Monoblastic AND (M5b) Monocytic Leukemia
- Problems

A
  • Bleeding problems common at presentation
  • Cutaneous and gingival infiltration
  • CNS involvement common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

APL treatment

A
  • Prescribe ATRA

- Manage coagulopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
After chemotherapy patients often develop severe leukcytopenia so what do we do to concentrate the cells for a differential?
We make a buffy coat smear by adding EDTA-anticoag blood into a WINTROBE tube
26
Treatment/Therapy: oral or parenteral cancer treatment with compounds that posses anti tumor properties
Chemotherapy
27
(M7) AML-NOS- Megakaryoblastic | - BM and stains
- Usually dry tap - MBO/SBB- negative - Factor VIII stain-pos
28
When a slide from a patient with APL is stained with MPO, what will it look like?
Strongly positive
29
The platelet count of a patient w/ an untreated acute leukemia is characteristically ____
Decreased
30
AML w/ abnormal marrow eosinophils | - Age group affected
Primarily young adults
31
Treatment/Therapy: use of ionizing energy to kill malignant cells by damaging DNA
Radiation
32
AML w/ maturation | - Prognosis
- Good in adults but poor in children | - Responds well w/ chemotherapy
33
Acute lymphoblastic leukemia (ALL) | - Onset b/w what years of age?
1-5 years (peaks b/w 2-3 years of age)
34
FAB nomenclature for AML-NOS acute monoblastic leukemia
M5a
35
Acute lymphoblastic leukemia (ALL) | - Purpose of immunophenotyping
- Distinguish blasts as lymphocytic in origin and not myeloid - Distinguish between B Cell or T Cell - Determines maturity of B or T cells
36
AML Therapy-related myeloid neoplasms | - Why does it occur
Occurs as a result of therapy-related cytotoxic chemotherapy and/or radiation therapy
37
(M4) AML -NOS Myelomonocytic | - Stains
Blasts will be positive for both myeloid and monocytic markers (MPO+) (ANBE +)
38
In Acute Promyelocytic Leukemia (APL), t(15;17) creates a fusion gene. What is it?
PML-RARA
39
Acute Myeloid Leukemia (AML) affects elements in which cell lineages?
- Granulocytic - Monocytic - Erythroid - Megakaryocytic
40
Will APL have Auer rods?
YES!! They'll have multiple Auer rods (faggot cells)
41
FAB nomenclature for AML-NOS acute megakaryocytic leukemia
M7
42
Patient's own stem cells are removed, conditioned, and transplanted back into the patient
Autologous stem cell transplant
43
APL lab results
- DIC/fibrinolysis coagulation - Thrombocytopenia - Hyper or microgranular promyelocytes
44
AML-NOS Erythroleukemia (erythroid/myeloid) | - PAS stain
PAS- positive in RBC precursors, chunky
45
AML w/ Myelodysplasia-Related Changes | - AMLs are in this category
- AML evolving from previous myelodysplastic syndrome | - AML with cytogenetic abnormalites that marrow those of MDS syndromes
46
FAB nomenclature for AML-NOS acute erythroleukemia
M6
47
What six immature cells will you find in AML?
- Myeloblasts - Promyelocytes - Monoblasts - Promonocytes - Erythroblasts - Megakaryoblasts
48
AML affects what age group?
All ages, predominated in adults around 65 years of age
49
Acute vs. chronic | - Course if treated
Acute: < 6 month survival Chronic: 2-6 years
50
Two different types of APL
- Typical (60-70%) | - Atypical (30-40%)
51
T cell leukemias always involve the _____ ______ and frequently develop lesions in _____ _____or other organs
Bone marrow | Lymph nodes
52
(M2) AML-NOS With Maturation - MPO - Auer Rods? - age affected
- MPO positive - Frequent Auer rods - All age groups
53
(M4) AML -NOS Myelomonocytic | - Bone marrow
- Myeloblasts > 20% | - Monocyte components
54
AML-NOS Acute Panmyelosis with Myelobibrosis (APMF) - clinical - increase in what?
- Bone pain and extensive myelofibrosis | - INcreased blasts of all myeloid lines
55
T-ALL patients have increased risk for what?
- Risk for induction failure - Early relapse - Isolated CNS relapse
56
(M4) AML -NOS Myelomonocytic - Peripheral blood - Auer rods?
- Myeloblasts - Monocytoid cells - thromobcytopenia - Auer rods +/-
57
AML w/ maturation | - Age affected
- 25-30 years old | - Predominant in children and young adults
58
What type of cancer is the most common cancer of childhood?
B-cell ALL
59
Acute Myeloid Leukemia (AML) will have recurrent cytogenic abnormalities: _______ - addition or deletion of part of - or entire- chromosome _______ primarily translocations and inversions
Numerical; structural
60
FAB nomenclature for AML-NOS Acute myelomonocytic leukemia (AMML)
M4
61
Acute lymphoblastic leukemia (ALL) | - Terminology used in B cell leukemia list in order
- Pro B-Cell - Pre-Pre B-Cell - Pre B-Cell
62
Acute lymphoblastic leukemia (ALL) | - Prognosis
- Depends upon lineage, cytogenetics, cell burden, and organomegaly - survival is >85% - poor prognosis if <1 year of age
63
AML w/ abnormal eosinophils | - Cytogenetic abnormality
inv(16)(p13.1;q22) | t(16;16) (p13.1;q22)
64
If a patient has an untreated leukemia, his/her BM is most likely ____
Hypercellular
65
AML not otherwise specified (NOS) | - Divisions within this category are based primarily off of what?
Morphological and cytochemical/immunophenotypic features
66
(M7) AML-NOS- Megakaryoblastic | - PB
- Micromegakaryocytes | - Pleomorphic blasts, blasts with agranular cytoplasm
67
AML w/ abnormal marrow eosinophils in the bone marrow
- Myeloblasts and promyelocytes (30-80%) - Monocytic component (>20%) - >5% eosinophils (all stages of maturation)
68
Acute vs. chronic | - Maturity of cells
Acute: immature Chronic: mature
69
Donor is genetically different than the patient
Allogenic stem cell transplant
70
(M0) AML-NOS Minimal Differentiation | - What stains are negative?
MPO and most other stains are negative
71
Acute vs. chronic | - Thrombocytopenia
Acute: mild to severe Chronic: mild
72
AML- Therapy-Related Myeloid Neoplasms - Age affected - Prognosis
- Age affected: median age 61 | - Poor prognosis (< 10% 5 year survival rate)
73
Genes that code for proteins that help cells resist malignant transformation
Tumor suppressor gene
74
AML w/ maturation in the peripheral blood
- Blasts with numerous azurophilic granules - Some may have very large granules (Pseudo-Chediak-Higashi) - Auer Rods likely
75
(M0) AML-NOS Minimal Differentiation - MPX/SBB stains - Auer rods?
Negative/no Auer rods
76
Acute vs. chronic | - WBC count
Acute: variable Chronic: increased
77
Two types of chemotherapy
- Phase specific | - Phase nonspecific
78
Codes for a protein found in normal cell cycle regulation. Mutation my form an oncogene and result in disruption of normal cell cycle
Proto-oncogene
79
Acute leukemia etiology
- Oncogenic viruses - Genetic and congenital factors - Ionizing radiation - Chemical agents - Unknown
80
Which of the two types of APL has microgranular promyelocytes and nuclei that are predominantly deeply notched/bilobed (butterfly)?
Atypical
81
The PML-RARA fusion gene leads to what?
Uncontrolled proliferation and inhibition of cellular differentiation
82
(M0) AML-NOS Minimal Differentiation in the peripheral blood
Blasts: medium, round (1-2 nucleoli), fine chromatin, cytoplasm is AGRANULAR and BASOPHILIC
83
AML-NOS-Basopilic Leukemia | - increased what?
Blasts and immature basos
84
Morphology of acute leukemias
- Decreased platelets, anemia (due to BM failure) - Blast Cells - Auer Rods (in some MYELOID never LYMPHOID)
85
Acute promyelocytic leukemia (APL) | - Cytogenetic abnormality
t(15;17)(q24;q21)
86
FAB nomenclature for AML w/ reuccrent cytogenetic abnormalities--AML w/ abnormal marrow eosinophils
M4eo
87
AML immunophenotyping
CD34+, HLA-DR+, CD117+, CD13+, CD33+ | the last two are very specific to AML
88
FAB nomenclature for AML-NOS w/ maturation
M2
89
Acute lymphoblastic leukemia (ALL) | - Cytochemistry
- Myeloperoxidase: Negative - Sudan Black B: Negative - ANBe: Positive/Negative focal - Periodic Acid Schiff: may be positive with BLOCK positivity
90
AML w/ myelodysplasia-related changes | - Prognosis
Poor
91
AML in the peripheral blood
- Variable leukocytosis - variable displasia - myeloblasts present in 95% of patients - Leukemic hiatus
92
(M0) AML-NOS Minimal Differentiation | - Age affected
Infants and older adults
93
AML w/ abnormal marrow eosinophils | - Prognosis
Favorable to average risk
94
Tumor suppressor genes cause cancers such as acute leukemias when mutations result in what?
Failure to prevent malignant processes
95
Having too many myeloblasts and some segs w/ no intemediate stages is known as what?
Leukemic hiatus
96
How will someone present clinically w/ AML?
- Pallor, fatigue - Fever/infection - Bruising/bleeding - Malignant cell infiltration into other tissues
97
FAB nomenclature for AML w/ recurrent cytogenetic abnormalities--Acute Promyelocytic Leukemia t(15;17) (APL)
M3
98
Cell growth occurs in what 4 tissues in acute leukemias?
- Parenchymal organs/skin - Thymus - Cerebral meninges - Testes
99
FAB nomenclature for AML-NOS w/ minimal differentiation
M0
100
AML w/ maturation | - Fusion gene
RUNX1-RUNX1T1
101
Acute vs. chronic | - Age of onset
Acute: all ages Chronic: adult
102
AML-NOS Acute Erythroid Leukemia | - Two subclasses
- Erythroleukemia (erythroid and myeloblasts in BM) | - Pure Erythroid leukemia (only erythroid precursors in BM)
103
Acute lymphoblastic leukemia (ALL) | - Morphology
- Anemia - Thombocytopenia - Blasts +/- - small blasts, more common usually pre B-Cell - large blasts, usually pre T-Cell
104
(M5a) AML-NOS-Acute Monoblastic AND (M5b) Monocytic Leukemia - ANBE stain
ANBE: positive
105
FAB nomenclature for AML-NOS w/o differentiation
M1
106
AML in the BM
- Hypercellular increased blasts - >20% blasts with limited maturation - variable dysplasia
107
AML w/ myelodysplasia-related changes | - Age range affected
Elderly population
108
Treatment/Therapy: Involves the use of pharmaceuticals to manage symptoms of malignancies and malignancy treatments including colony stimulating factors and erythropietin
Supportive therapy